New hope to stop aggressive breast cancer from coming back
NCT ID NCT07441460
Summary
This large study aims to see if a new combination of targeted drugs (KN026 and HB1801) with chemotherapy works better than the current standard treatment to keep HER2-positive breast cancer from returning after surgery. It will involve about 1,800 patients who have had surgery but are at risk of the cancer coming back. The main goal is to measure how long patients remain cancer-free after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.